| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039593705 |
| P356 | DOI | 10.1038/SJ.ONC.1206397 |
| P698 | PubMed publication ID | 12771942 |
| P5875 | ResearchGate publication ID | 7131796 |
| P2093 | author name string | J Anton Grootegoed | |
| Leen J Blok | |||
| Josien K Oosterhoff | |||
| Albert O Brinkmann | |||
| Fred Penninkhof | |||
| P2860 | cites work | The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity | Q37544438 |
| Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DU145, and LNCaP prostatic cancer cell lines: relationship with DNA ploidy level | Q39368327 | ||
| The post-translational modifications of Ral and Rac1 are important for the action of Ral-binding protein 1, a putative effector protein of Ral. | Q41103610 | ||
| Control of EGF receptor signaling by clathrin-mediated endocytosis. | Q45345953 | ||
| Endocytosis proteins and cancer: a potential link? | Q47686987 | ||
| An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs | Q22066003 | ||
| Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral | Q24318512 | ||
| Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity | Q24337472 | ||
| Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors | Q24534185 | ||
| Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases | Q24651430 | ||
| Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
| The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway | Q29614258 | ||
| Endocytosis and mitogenic signaling | Q33712434 | ||
| Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways | Q33774714 | ||
| Regulation of complex formation of POB1/epsin/adaptor protein complex 2 by mitotic phosphorylation | Q33898116 | ||
| Suppression of Ras-induced apoptosis by the Rac GTPase | Q33959056 | ||
| Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival | Q33959533 | ||
| Ras and Rho regulation of the cell cycle and oncogenesis | Q34326213 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2920-2925 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells | |
| P478 | volume | 22 |
| Q36857274 | Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling |
| Q43185634 | Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity. |
| Q34354134 | EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2. |
| Q42119540 | Epsins' novel role in cancer cell invasion |
| Q37146994 | Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates |
| Q33832517 | Gene expression pathways of high grade localized prostate cancer |
| Q36744205 | Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1 |
| Q34325532 | Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells |
| Q51836057 | Identification of a microdeletion at Xp22.13 in a Taiwanese family presenting with Nance-Horan syndrome |
| Q36043833 | Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients |
| Q47340259 | RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer |
| Q37741408 | RLIP76 Targeted Therapy for Kidney Cancer |
| Q38749340 | RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer |
| Q37146979 | RLIP76: A novel glutathione-conjugate and multi-drug transporter |
| Q33867008 | RLIP76: a versatile transporter and an emerging target for cancer therapy |
| Q36408355 | Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases |
| Q37194622 | Regression of prostate cancer xenografts by RLIP76 depletion |
| Q30051796 | Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 |
| Q37154223 | Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. |
| Q35083727 | The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery |
| Q24316124 | The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteins |
| Q24295295 | The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion |
| Q36609767 | Therapeutic resistance in lung cancer |
| Q47095142 | Transcriptional profiling of Toll-like receptor 2-deficient primary murine brain cells during Toxoplasma gondii infection |
| Q37327593 | miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2. |
Search more.